M. Salzer‐Kuntschik

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Stefan Bielack, Beate Kempf‐Bielack, G. Delling et al. · Journal of Clinical Oncology · 2002 · 1.8K citations

Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Leo Kager, A. Zoubek, Ulrike Pötschger et al. · Journal of Clinical Oncology · 2003 · 939 citations

MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration

Inge M. Ambros, Peter F. Ambros, Sabine Strehl et al. · Cancer · 1991 · 655 citations · Full text

Specific Chromosome Aberration, Tumoral Pathology, Y Chromosomes +15

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.

K. Winkler, G. Beron, R. Kotz et al. · Journal of Clinical Oncology · 1984 · 349 citations

Surgical Oncology, Cancer Management, Adjuvant Chemotherapy +17

Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

N. Fuchs, Stefan Bielack, D. Epler et al. · Annals of Oncology · 1998 · 346 citations · Full text

Intensive Multidrug Chemotherapy, Protocol Coss-86, Surgical Oncology +7